NOTV

Inotiv, Inc.
5 filings tracked
healthcarebiotechnologySMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Inotiv, Inc. has moved to stabilize its financial foundation by entering into a $65.5 million superpriority debtor-in-possession credit facility.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The company's financial position remains precarious as it faces a 11.5% interest rate on its new DIP loans and a looming Nasdaq delisting.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every NOTV filing.

Start Free Trial

Synthesis (Verdict & Resolution)

Inotiv's filing marks a definitive shift from public trading to a court-supervised restructuring process. While the DIP facility provides an immediate lifeline, the company's survival depends on its ability to meet rigid financial milestones and successfully execute a plan that currently favors creditors over shareholders. The transition to a private company via this process represents a high-stakes gamble on operational turnaround under the shadow of bankruptcy court oversight.

Selected Quarter

Core Takeaway

The company has secured emergency funding to operate during bankruptcy but is exiting the public markets.

Investor Lens

Investors must weigh the possibility of a successful private pivot against the near-certainty of equity cancellation.

Watch Next

The August 4, 2026, DIP termination date and the outcome of the prepackaged plan vote.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.53Q2 '26 (10-Q)-0.10Q2 '26 (8-K)

Signal Timeline

9 of 17
Active Filters:Quarter: Q2 '26 (8-K)
bullishJun 8

Secured $65.5M in DIP financing to fund Chapter 11 operations.

capital raise
60%
neutralJun 8

Company is transitioning to a private entity via bankruptcy reorganization.

management change
40%
bearishJun 8

Existing equity is expected to be cancelled without compensation.

dilution risk
90%
bullishJun 8

Secured $65.5M in DIP financing to fund Chapter 11 operations.

capital raise
60%
neutralJun 8

Company is transitioning to a private entity via bankruptcy reorganization.

management change
40%
bearishJun 8

Existing equity is expected to be cancelled without compensation.

dilution risk
90%
bullishJun 8

Secured $65.5M in DIP financing to fund Chapter 11 operations.

capital raise
60%
neutralJun 8

Company is transitioning to a private entity via bankruptcy reorganization.

management change
40%
bearishJun 8

Existing equity is expected to be cancelled without compensation.

dilution risk
90%

Filing History

8-KJun 8, 2026
Expand Sequence

Inotiv's filing marks a definitive shift from public trading to a court-supervised restructuring process. While the DIP facility provides an immediate lifeline, the company's survival depends on its ability to meet rigid financial milestones and successfully execute a plan that currently favors creditors over shareholders. The transition to a private company via this process represents a high-stakes gamble on operational turnaround under the shadow of bankruptcy court oversight.

10-QMay 11, 2026
Expand Sequence

Inotiv finds itself at a crossroads where strong commercial demand in its high-value DSA services is being overshadowed by a precarious capital structure. The divergence between the company's operational trajectory—characterized by a growing backlog and strategic modernization—and its financial stability—marked by a looming debt wall and liquidity shortages—creates a high-stakes environment for investors. The company's survival now hinges less on its ability to win contracts and more on its ability to execute a complex recapitalization or refinancing effort. The overall impact of the filing is a stark warning regarding the company's solvency. While the operational engine of the DSA business appears to be functioning, the interest burden and principal repayments are currently unsustainable. Investors are left to weigh the potential of a lean, modernized CRO against the very real possibility of a total loss should the company fail to secure a viable path through its upcoming debt maturities and covenant breaches.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.